Close Menu

Biocept

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – GE Healthcare's Clarient will commercialize Biocept's blood test for circulating tumor cells under a deal announced today.

Movers & Shakers: May 6, 2011

Premium

Lyle Arnold, Michael Dunn, Gilbert Omenn, Matthew Potter, David Bartel, Arthur Beaudet, George Church

People in the News: May 5, 2011

Premium

Lyle Arnold, Michael Dunn join Biocept management team; HTG appoints John Lubniewski as chief business officer; Ora Hirsch Pescovitz joins Life Tech's board

The company's first test, a FISH-based assay targeting breast cancer, is planned for October and would represent its first product introduction in its 13-year history.

IP Roundup: Sep 29, 2009

Premium

Rosetta Genomics, Hitachi, Biocept, Brigham and Women's Hospital, Tufts University

Pages

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.